secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2023-09-27T23:59:59+00:00
Accession:  0001437749-23-026947
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics increases authorized common stock from 12M to 350M, creates 5M blank check preferred
--------------------------------------------------------------------------------

- Authorized common shares increased from 12,000,000 to 350,000,000, par value $0.001.
- Authorized 5,000,000 shares of blank check preferred stock, par value $0.001.
- Amendment approved by board on July 18, 2023 and stockholders on August 22, 2023; effective September 21, 2023.
- No immediate purpose for the additional shares was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774923026947/0001437749-23-026947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774923026947/arch20230927_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-026947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer